Publication number: 20260243920
Abstract: A method for identifying icing zones of typical micro-terrain and micro-climate on transmission lines, including: Step 1, generating a DEM map with a range of 1.5 km×1.5 km centered on the tower's latitude and longitude; Step 2, filtering the DEM map; Step 3, extracting typical terrain feature factors of the icing zone using the maximum gradient algorithm based on the DEM map obtained in Step 2; Step 4, performing basic calculations based on the terrain feature factors in Step 3; Step 5, analyzing the terrain features to propose quantitative values applicable to each micro-terrain and micro-climate zone, determining whether there are high mountain watersheds, terrain uplift, mountain passes, canyon wind corridors, and increased water vapor; thus solving the problem of identifying icing conditions in different types of micro-terrain and micro-climate transmission lines.
Type:
Application
Filed:
April 9, 2026
Publication date:
August 20, 2026
Applicants:
State Grid Henan Electric Power Research institute, Chongqing Dige Technology Co., Ltd.
Inventors:
Degui Yao, Jinyu Wang, Xingliang Jiang, Zhe Li, Guolin Yang, Jiaying Ke, Lina Dong, Yun Liang, Lu Zhang, Kai Pang, Chao Wang, Ming Lu, Sikun Yuan, Yang Gao, Shuai Li, Jingjing Cui, Zhuojun Li
Patent number: 12698259
Abstract: Provided herein are compounds of Formula (I), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, prodrugs, compositions, and mixtures thereof. Also provided are methods and kits involving the inventive compounds or compositions for treating and/or preventing diseases (e.g., proliferative diseases (e.g., cancers, such as carcinoma, sarcoma, lung cancer, thyroid cancer, skin cancer, ovarian cancer, colorectal cancer, prostate cancer, pancreatic cancer, esophageal cancer, liver cancer, breast cancer)) in a subject. Provided are methods of inhibiting a TEAD transcription factors (e.g., TEAD1, TEAD2, TEAD3, TEAD4) in a subject.
Type:
Grant
Filed:
October 15, 2019
Date of Patent:
August 4, 2026
Assignee:
Dana-Farber Cancer Institute, Inc.
Inventors:
Nathanael S. Gray, Tinghu Zhang, Yao Liu, Mengyang Fan, Yang Gao